Announcement : SignalChem has changed its corporate name from “SignalChem Pharmaceutical Inc.” to “SignalChem Biotech Inc.” effective March 20th 2019.


SignalChem offers a diverse and comprehensive range of kinases, encompassing all of the major families, including: AGC, Atypical, CAMK, CMGC, CK1, STE, TK, TKL and others. Our enzymes are effective tools for drug discovery and functional biological studies.